Ari Melnick

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Cerchietti LC, Lopes EC, Yang SN, et al. (2024) Author Correction: A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas. Nature Medicine
Li J, Chin CR, Ying HY, et al. (2024) Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment. Nature Communications. 15: 2879
Deng Q, Lakra P, Gou P, et al. (2024) SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions. Cancer Cell
Barisic D, Chin CR, Meydan C, et al. (2024) ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. Cancer Cell
Safa FM, Rasmussen T, Fontan L, et al. (2023) Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application. Haematologica
Shah SB, Carlson CR, Lai K, et al. (2023) Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas. Nature Materials
Leca J, Lemonnier F, Meydan C, et al. (2023) IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment. Cancer Cell
Mlynarczyk C, Teater M, Pae J, et al. (2023) mutation yields supercompetitive B cells primed for malignant transformation. Science (New York, N.Y.). 379: eabj7412
Fortin J, Chiang MF, Meydan C, et al. (2023) Distinct and opposite effects of leukemogenic and mutations in hematopoietic stem and progenitor cells. Proceedings of the National Academy of Sciences of the United States of America. 120: e2208176120
Flumann R, Hansen J, Pelzer BW, et al. (2022) Distinct genetically-determined origins of Myd88/Bcl2-driven aggressive lymphoma rationalize targeted therapeutic intervention strategies. Blood Cancer Discovery